Jennifer B. Dennison

5.9k total citations · 1 hit paper
52 papers, 2.1k citations indexed

About

Jennifer B. Dennison is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jennifer B. Dennison has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Jennifer B. Dennison's work include Cancer, Hypoxia, and Metabolism (9 papers), Radiomics and Machine Learning in Medical Imaging (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Jennifer B. Dennison is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Radiomics and Machine Learning in Medical Imaging (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Jennifer B. Dennison collaborates with scholars based in United States, United Kingdom and Canada. Jennifer B. Dennison's co-authors include Stephen D. Hall, Jamie L. Renbarger, Susan D. Demo, Peter J. Shwonek, Timothy F. Stanton, Bindu Goyal, Matt I. Gross, Jun Li, Evan R. Lewis and Taotao Wang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jennifer B. Dennison

47 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

2014 797 citations Matt I. Gross, Susan D. Demo et al. Molecular Cancer Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer B. Dennison United States	21	1.3k	1.0k	583	237	216	52	2.1k
Maria M. Simile Italy	27	1.5k 1.2×	626 0.6×	442 0.8×	118 0.5×	83 0.4×	59	2.2k
Xiangjian Luo China	31	1.8k 1.4×	1.2k 1.2×	726 1.2×	279 1.2×	54 0.3×	71	2.9k
Fariba Behbod United States	26	1.6k 1.2×	715 0.7×	1.8k 3.0×	226 1.0×	113 0.5×	62	3.1k
Renee M. Balliet United States	13	1.1k 0.9×	790 0.8×	473 0.8×	99 0.4×	112 0.5×	13	1.8k
Dona Alberti United States	30	1.4k 1.1×	387 0.4×	1.0k 1.8×	419 1.8×	77 0.4×	90	2.8k
Johannes Roesel Switzerland	23	1.5k 1.1×	750 0.7×	419 0.7×	372 1.6×	44 0.2×	36	2.8k
Anna Kruczynski France	26	1.3k 1.0×	257 0.3×	779 1.3×	226 1.0×	110 0.5×	71	2.1k
Vijaykumar Holla United States	23	813 0.6×	648 0.6×	582 1.0×	398 1.7×	111 0.5×	50	2.1k
Amanda F. Baker United States	32	1.6k 1.2×	453 0.4×	606 1.0×	417 1.8×	32 0.1×	56	2.7k

Countries citing papers authored by Jennifer B. Dennison

Since Specialization

Citations

This map shows the geographic impact of Jennifer B. Dennison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer B. Dennison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer B. Dennison more than expected).

Fields of papers citing papers by Jennifer B. Dennison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer B. Dennison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer B. Dennison. The network helps show where Jennifer B. Dennison may publish in the future.

Co-authorship network of co-authors of Jennifer B. Dennison

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer B. Dennison. A scholar is included among the top collaborators of Jennifer B. Dennison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer B. Dennison. Jennifer B. Dennison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fahrmann, Johannes F., Michele Yip-Schneider, Jennifer B. Dennison, et al.. (2025). Lead time trajectory of blood-based protein biomarkers for detection of pancreatic cancer based on repeat testing. Cancer Letters. 612. 217450–217450. 4 indexed citations

Chen, Yihui, So‐Young Park, Jody V. Vykoukal, et al.. (2025). Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer Cells. Vaccines. 13(6). 629–629.

Irajizad, Ehsan, James P. Long, Johannes F. Fahrmann, et al.. (2025). Impact of Comorbidities on the Mortality Benefits of Lung Cancer Screening: A Post-Hoc Analysis of the PLCO and NLST Trials. Journal of Thoracic Oncology. 20(5). 565–576. 3 indexed citations

Chen, Yihui, Rongzhang Dou, Ehsan Irajizad, et al.. (2025). Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of Progression. Clinical Cancer Research. 31(12). 2454–2465.

Vachani, Anil, Luis Seijó, Gorka Bastarrika, et al.. (2025). AI-assisted Lung Cancer Screening: Results From REALITY, A Pivotal Validation Study of an AI/ML-based Algorithm. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5223–A5223. 1 indexed citations

Chen, Yihui, et al.. (2023). c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy. Cancers. 15(3). 623–623. 8 indexed citations

Fahrmann, Johannes F., Ehsan Irajizad, Edwin J. Ostrin, et al.. (2023). Mortality benefit of a blood-based biomarker panel for lung cancer and the PLCO cohort.. Journal of Clinical Oncology. 41(16_suppl). 8560–8560. 1 indexed citations

Chen, Yihui, Ranran Wu, Ehsan Irajizad, et al.. (2023). Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis. Cancers. 15(3). 834–834. 18 indexed citations

Irajizad, Ehsan, Johannes F. Fahrmann, Tracey L. Marsh, et al.. (2023). Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. Journal of Clinical Oncology. 41(27). 4360–4368. 10 indexed citations

10.

Fahrmann, Johannes F., Tracey L. Marsh, Ehsan Irajizad, et al.. (2022). Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. Journal of Clinical Oncology. 40(8). 876–883. 57 indexed citations

11.

Vykoukal, Jody V., Johannes F. Fahrmann, Nikul Patel, et al.. (2022). Contributions of Circulating microRNAs for Early Detection of Lung Cancer. Cancers. 14(17). 4221–4221. 21 indexed citations

12.

Irajizad, Ehsan, Chae Young Han, Joseph Celestino, et al.. (2022). A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses. Clinical Cancer Research. 28(21). 4669–4676. 10 indexed citations

13.

Fahrmann, Johannes F., Hiroyuki Katayama, Ehsan Irajizad, et al.. (2021). Plasma Based Protein Signatures Associated with Small Cell Lung Cancer. Cancers. 13(16). 3972–3972. 6 indexed citations

14.

Vykoukal, Jody V., Johannes F. Fahrmann, Justin R. Gregg, et al.. (2020). Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer. Nature Communications. 11(1). 4279–4279. 50 indexed citations

15.

Tripathi, S. C., Johannes F. Fahrmann, Müge Çeliktaş, et al.. (2017). MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway. Cancer Research. 77(16). 4414–4425. 85 indexed citations

16.

Dennison, Jennifer B., Maria Shahmoradgoli, Wenbin Liu, et al.. (2016). High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype. Clinical Cancer Research. 22(20). 5068–5078. 26 indexed citations

17.

Gross, Matt I., Susan D. Demo, Jennifer B. Dennison, et al.. (2014). Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 13(4). 890–901. 797 indexed citations breakdown →

18.

Dennison, Jennifer B., Jennifer R. Molina, Shreya Mitra, et al.. (2013). Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer. Clinical Cancer Research. 19(13). 3703–3713. 93 indexed citations

19.

Cheong, Jae‐Ho, Eun Sung Park, Jiyong Liang, et al.. (2011). Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models. Molecular Cancer Therapeutics. 10(12). 2350–2362. 205 indexed citations

20.

Stellrecht, Christine M., Kumudha Balakrishnan, Jennifer B. Dennison, et al.. (2011). Abstract 3781: The ribonucleoside analog, 8-chloro-adenosine, induces autophagy in primary chronic lymphocytic leukemia cells in vitro and in vivo. Cancer Research. 71(8_Supplement). 3781–3781. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact